TARGET-IBD Poster & Oral Presentation at ECCO
Novel Analgesics with Peripheral Targets | SpringerLink
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Education
PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
Expect more? Empty shelves frustrate Target customers, execs | MPR News
New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn's Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) | Business Wire
Therapeutic targets in inflammatory bowel disease | Revista Médica Clínica Las Condes
Conference Highlights - ECCO 2020: subcutaneous-vedolizumab-maintenance-therapy-in-cd
Review: THE TARGET by David Baldacci (Macmillan/Grand Central) | Civilian Reader
Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence
Value Chain Analysis
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease - Clinical Gastroenterology and Hepatology
Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect
PDF) ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
Education
ECCO Portal
3D TARGET SRL | LinkedIn
Objective evaluation for treat to target in Crohn's disease | SpringerLink
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis - Allen - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
TARGET-IBD Poster & Oral Presentation at ECCO
Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease - Day - 2020 - JGH Open - Wiley Online Library
RNAO - ECCO MODEL 3.0
ECCO Portal
